Supplier
Eye Care Center of Napa Valley a Medical Corporation
Eye Care Center of Napa Valley a Medical Corporation was paid $3.72M by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 28% of everything it billed.
33Billing provider infoEYE CARE CENTER OF NAPA VALLEY A MEDICAL CORPORATION
NAPA, CA 94558
NAPA, CA 94558
33aNPI1790781409assigned 06/27/2005
33bProvider typeEyewear Supplier
28Total paid$3.72M
24GClaims33,114
24DCodes billed23
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Eyewear Supplier providers in California
Rank by total paid#5 of 43
Median peer was paid$35K
This provider vs. median107×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,217 | $201K | |
| 2019 | 3,544 | $263K | |
| 2020 | 2,843 | $243K | |
| 2021 | 4,501 | $560K | |
| 2022 | 5,627 | $784K | |
| 2023 | 7,308 | $935K | |
| 2024incomplete | 6,074 | $732K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 28% | 3,914 | 3,126 | $1.05M |
| J0178 | Injection, aflibercept, 1 mg | 27% | 1,055 | 946 | $988K |
| J2778 | Injection, ranibizumab, 0.1 mg | 15% | 915 | 752 | $544K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.7% | 7,228 | 6,601 | $285K |
| 92134 | 4.4% | 5,546 | 4,768 | $165K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.5% | 4,178 | 3,867 | $129K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 2.7% | 146 | 114 | $100K |
| 92250 | 2.2% | 1,941 | 1,877 | $81K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.2% | 933 | 918 | $81K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 2.1% | 91 | 80 | $80K |
| 92083 | 1.4% | 1,765 | 1,723 | $53K | |
| 92133 | 1.3% | 1,434 | 1,390 | $47K |
11 more codes
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.1% | 1,773 | $42K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 357 | $32K |
| 92136 | <1% | 323 | $12K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 844 | $12K |
| 92015 | Determination of refractive state | <1% | 410 | $5K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 64 | $4K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 69 | $3K |
| 92235 | <1% | 26 | $2K | |
| 92020 | <1% | 39 | $869.70 | |
| 76514 | <1% | 47 | $338.60 | |
| 92025 | <1% | 16 | $284.74 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURKE, KENA (PRACTICE ADMINISTRATOR)